BALAXI PHARMACEUTICALS
Quarterly Results Analysis [Sep2024]
BALAXI PHARMACEUTICALS Quarterly Results
Consolidated | Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 Audited |
Sep2023 Audited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹77 Cr | ₹66 Cr | ₹60 Cr | ₹61 Cr | ₹55 Cr | ₹66 Cr | ₹81 Cr | ₹87 Cr |
Expenses | ₹67 Cr | ₹56 Cr | ₹46 Cr | ₹47 Cr | ₹44 Cr | ₹57 Cr | ₹68 Cr | ₹71 Cr |
Operating Income | ₹11 Cr | ₹10 Cr | ₹13 Cr | ₹14 Cr | ₹11 Cr | ₹9 Cr | ₹13 Cr | ₹15 Cr |
Other Income | ₹-4 Cr | ₹-2 Cr | ₹-2 Cr | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹0 Cr | ₹-5 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr |
Profit Before Tax | ₹6 Cr | ₹7 Cr | ₹11 Cr | ₹14 Cr | ₹16 Cr | ₹-39 Cr | ₹11 Cr | ₹11 Cr |
Profit After Tax | ₹5 Cr | ₹6 Cr | ₹11 Cr | ₹14 Cr | ₹14 Cr | ₹-41 Cr | ₹8 Cr | ₹8 Cr |
EPS | ₹0.83 | ₹1.17 | ₹2.01 | ₹2.66 | ₹14.10 | ₹-8.08 | ₹1.59 | ₹1.64 |
Industry Peers & Returns | 1W | 1M | 1Y |
BALAXI PHARMACEUTICALS | 0.2% | -6.2% | -22% |
ADANI ENTERPRISES | -5.2% | -5.8% | -28.2% |
REDINGTON | -0.1% | -4% | 15.3% |
HONASA CONSUMER | -0.6% | -1.6% | -48.8% |
MMTC | -9.3% | -13.4% | 0.2% |
MSTC | -10.3% | -18.2% | -13.2% |
LLOYDS ENTERPRISES | -7.2% | 8.2% | 52.4% |
VERITAS (INDIA) | -7.1% | -19.3% | 45.6% |
NOVARTIS INDIA | -6.7% | -15.8% | 1.1% |
BALAXI PHARMACEUTICALS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 17.92 % |
Y-o-Y | 41.41 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Sep2024 | ₹77 Cr | 17.92 | |
Jun2024 | ₹66 Cr | 9.68 | |
Mar2024 | ₹60 Cr | -1.57 | |
Dec2023 | ₹61 Cr | 11.08 | |
Sep2023 | ₹55 Cr | -17.03 | |
Jun2023 | ₹66 Cr | -18.25 | |
Mar2023 | ₹81 Cr | -6.81 | |
Dec2022 | ₹87 Cr | - |
BALAXI PHARMACEUTICALS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 4.97 % |
Y-o-Y | -1.64 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Sep2024 | ₹11 Cr | 4.97 | |
Jun2024 | ₹10 Cr | -25.11 | |
Mar2024 | ₹13 Cr | -1.41 | |
Dec2023 | ₹14 Cr | 26.90 | |
Sep2023 | ₹11 Cr | 21.76 | |
Jun2023 | ₹9 Cr | -30.63 | |
Mar2023 | ₹13 Cr | -16.66 | |
Dec2022 | ₹15 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -11.00 % |
Y-o-Y | -30.45 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Sep2024 | 13.68% | -11.00 | |
Jun2024 | 15.37% | -31.72 | |
Mar2024 | 22.51% | 0.18 | |
Dec2023 | 22.47% | 14.23 | |
Sep2023 | 19.67% | 46.79 | |
Jun2023 | 13.4% | -15.19 | |
Mar2023 | 15.8% | -10.53 | |
Dec2022 | 17.66% | - |
BALAXI PHARMACEUTICALS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -29.20 % |
Y-o-Y | -68.20 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Sep2024 | ₹5 Cr | -29.20 | |
Jun2024 | ₹6 Cr | -40.74 | |
Mar2024 | ₹11 Cr | -19.57 | |
Dec2023 | ₹14 Cr | -5.78 | |
Sep2023 | ₹14 Cr | Positive | |
Jun2023 | ₹-41 Cr | Negative | |
Mar2023 | ₹8 Cr | -1.59 | |
Dec2022 | ₹8 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -39.92 % |
Y-o-Y | -77.51 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Sep2024 | 5.93 % | -39.92 | |
Jun2024 | 9.87 % | -45.98 | |
Mar2024 | 18.27 % | -18.29 | |
Dec2023 | 22.36 % | -15.21 | |
Sep2023 | 26.37 % | Positive | |
Jun2023 | -62.68 % | Negative | |
Mar2023 | 10.04 % | 5.68 | |
Dec2022 | 9.5 % | - |
BALAXI PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -29.06 % |
Y-o-Y | -94.11 % |
Quarters | EPS | % Change | |
---|---|---|---|
Sep2024 | ₹0.83 | -29.06 | |
Jun2024 | ₹1.17 | -41.79 | |
Mar2024 | ₹2.01 | -24.44 | |
Dec2023 | ₹2.66 | -81.13 | |
Sep2023 | ₹14.1 | Positive | |
Jun2023 | ₹-8.08 | Negative | |
Mar2023 | ₹1.59 | -3.05 | |
Dec2022 | ₹1.64 | - |
You may also like the below Video Courses
ADANI ENTERPRISES LTD vs REDINGTON LTD vs HONASA CONSUMER LTD
MMTC LTD vs MSTC LTD vs LLOYDS ENTERPRISES LTD